Aeon Respire

3:45 PM - 4:00 PM (PDT), Monday, June 13, 2022
Aeon Respire is a therapeutics company with a patent-protected lead program under development for severe asthma, COPD and other respiratory diseases. The approach is based on cutting edge inhalation technology and a new and differentiating mechanism of action.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2019
Main Therapeutic Focus:
Lead Product in Development:
AR-001
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
1
Speaker
photo
VP, R&D
Aeon Respire